KROS · Keros Therapeutics, Inc.
Market Cap
$218.69M
Shares
19.83M
Keros Therapeutics, Inc. Earnings Call Transcripts
Quarterly earnings calls for Keros Therapeutics, Inc. (KROS), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.
Conference
Investor event
2026-06-08
Keros Therapeutics, Inc. (KROS) June 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY23 · Q2
2023-08-07
Keros Therapeutics, Inc. (KROS) Q2 2023 Earnings Call
Revenue
$
Diluted EPS
$-1.27
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Showing 1–2 of 2 earnings calls
Key facts
CIK
1664710
CUSIP
492327101
13F (30d)
115 filings
114 filers
Visit website
Investor relations